These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 9170337

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat.
    Hoskin KL, Goadsby PJ.
    Exp Neurol; 1998 Mar; 150(1):45-51. PubMed ID: 9514827
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine?
    Goadsby PJ, Hoskin KL.
    Pain; 1996 Oct; 67(2-3):355-9. PubMed ID: 8951929
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Intensity dependence of the cortical auditory evoked potentials as a surrogate marker of central nervous system serotonin transmission in man: demonstration of a central effect for the 5HT1B/1D agonist zolmitriptan (311C90, Zomig).
    Proietti-Cecchini A, Afra J, Schoenen J.
    Cephalalgia; 1997 Dec; 17(8):849-54; discussion 799. PubMed ID: 9453273
    [Abstract] [Full Text] [Related]

  • 7. Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan).
    Martin GR, Robertson AD, MacLennan SJ, Prentice DJ, Barrett VJ, Buckingham J, Honey AC, Giles H, Moncada S.
    Br J Pharmacol; 1997 May; 121(2):157-64. PubMed ID: 9154322
    [Abstract] [Full Text] [Related]

  • 8. Joint 1994 Wolff Award Presentation. Peripheral and central trigeminovascular activation in cat is blocked by the serotonin (5HT)-1D receptor agonist 311C90.
    Goadsby PJ, Edvinsson L.
    Headache; 1994 May; 34(7):394-9. PubMed ID: 7928323
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tolerability profile of zolmitriptan (Zomig; 311C90), a novel dual central and peripherally acting 5HT1B/1D agonist. International clinical experience based on > 3000 subjects treated with zolmitriptan.
    Edmeads JG, Millson DS.
    Cephalalgia; 1997 Oct; 17 Suppl 18():41-52. PubMed ID: 9399016
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The interaction between propranolol and the novel antimigraine agent zolmitriptan (311C90).
    Peck RW, Seaber EJ, Dixon R, Gillotin CG, Weatherley BC, Layton G, Posner J.
    Br J Clin Pharmacol; 1997 Dec; 44(6):595-9. PubMed ID: 9431839
    [Abstract] [Full Text] [Related]

  • 15. Zolmitriptan (Zomig, 311C90), a novel dual central and peripheral 5HT1B/1D agonist: an overview of efficacy.
    Schoenen J, Sawyer J.
    Cephalalgia; 1997 Oct; 17 Suppl 18():28-40. PubMed ID: 9399015
    [Abstract] [Full Text] [Related]

  • 16. Lack of an effect of zolmitriptan (Zomig, 311C90) on psychometric task performance: results of a placebo-controlled study in healthy volunteers.
    Mercer AJ, Lamb RJ, Rolan PE, Gibbens M, Posner J.
    Psychopharmacology (Berl); 1998 Dec; 140(4):398-404. PubMed ID: 9888613
    [Abstract] [Full Text] [Related]

  • 17. Zolmitriptan reverses blink reflex changes induced during the migraine attack in humans.
    de Tommaso M, Guido M, Libro G, Sciruicchio V, Puca F.
    Neurosci Lett; 2000 Jul 28; 289(1):57-60. PubMed ID: 10899408
    [Abstract] [Full Text] [Related]

  • 18. The pharmacokinetics and effects on blood pressure of multiple doses of the novel anti-migraine drug zolmitriptan (311C90) in healthy volunteers.
    Dixon R, Gillotin C, Gibbens M, Posner J, Peck RW.
    Br J Clin Pharmacol; 1997 Mar 28; 43(3):273-81. PubMed ID: 9088582
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.